India is on the wrong side of the AI trade, warns Nirav Sheth. Foreign investors are chasing AI growth abroad, impacting Indian markets. In...

On the eve of Mumbai Tech Week, Sharad Sanghi of Neysa AI, Aakrit Vaish of Activate, and Naiyya Saggi of EDT spoke with ETtech editor Samid...

Pregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims t...

India's economic path may lie in an unusual strategy. The nation is advised to focus on producing items people do not need. This approach a...

A content creator named Kaajal recently shared on Instagram that she lost 5 kg in just four weeks after starting Mounjaro, calling the rapi...

More than 53 million retired Americans now depend on Social Security benefits every month. Yet millions still lose retirement income becaus...

India's healthcare is changing. Value is moving from hospitals to patients' daily lives. A new 'phydigital' model combines physical and dig...

Sir William Osler, a pioneering physician, advocated for holistic patient care. He believed doctors should consider the entire person, not ...

Weight-loss drugs are being sold without prescriptions in India. This is causing alarm among doctors and authorities. People are buying the...

India's government has released strict rules for GLP-1 drugs, used for diabetes and obesity. These powerful medications are now prescriptio...

GLP-1 weight loss drugs: Renowned cardiovascular surgeon Dr. Naresh Trehan has issued a stern warning against the unsupervised use of GLP-1...

The government is looking to control the sale of Pregabalin. This common medicine is being misused. The government wants to make sure it is...

Illegible prescriptions pose serious risks to patient safety, according to Dr. Sudhir Kumar, a senior neurologist trained at CMC Vellore an...

The Supreme Court rejected a plea requiring doctors to list all drug side effects for patients in their regional language. The court deemed...

"Since the legislature in its wisdom has elected to impose this duty on the manufacturer and the pharmacist (to state about side effects), ...

The Delhi High Court has dismissed a Public Interest Litigation (PIL) seeking direction from the Centre to mandate all medical professional...

Belgium life science company, Kitozyme entered into in-licensing agreement with Corona Remedies for fat binder anti-obesity drug.